JAMJOOM PHARMACEUTICALS FACTORY COMPANY SJSC TADAWUL:4015:
JAMJOOM PHARMA - STRIKES STRATEGIC DEAL WITH BIO-THERA FOR SECURING COSENTYX BIOSIMILAR IN MENA
JAMJOOM PHARMA - UNDER DEAL, CO WILL OBTAIN EXCLUSIVE RIGHTS TO COMMERCIALIZE BAT2306 ACROSS MENA REGION
JAMJOOM PHARMA WILL MANAGE REGULATORY SUBMISSIONS, MARKET ACCESS, AND COMMERCIALIZATION IN MENA
BIO-THERA WILL OVERSEE PRODUCT DEVELOPMENT AND GLOBAL MANUFACTURING FROM ITS STATE-OF-THE-ART FACILITIES IN GUANGZHOU, CHINA